Hospital Supply Status (HSS) and Principal Supply Status (PSS) - Cumulative to July 2025
The expiry date of the supply period is 30 June of the year indicated unless otherwise stated. Please note that the supply may have been awarded for a wider scope than just those presentation(s) listed below.
| Status | Chemical | Presentation | Brand | Pharmacode | SSS/PSS Period |
|---|---|---|---|---|---|
| PSS | Acarbose | Tab 100 mg | Accarb | 2402416 | Feb 2025 to 2027 |
| PSS | Acarbose | Tab 50 mg | Accarb | 2402408 | Feb 2025 to 2027 |
| PSS | Acetazolamide | Tab 250 mg | Medsurge | 2670801 | Sep 2025 to 2027 |
| PSS | Acetylcysteine | Inj 200 mg per ml, 10 ml ampoule | DBL Acetylcysteine | 2260794 | Apr 2025 to 2027 |
| PSS | Aciclovir | Eye oint 3% | ViruPOS | 2490803 | Feb 2025 to 2027 |
| PSS | Aciclovir | Inj 250 mg vial | Aciclovir-Baxter | 2599414 | Feb 2025 to 2027 |
| PSS | Acitretin | Cap 10 mg | Novatretin | 2384167 | Jul 2024 to 2026 |
| PSS | Acitretin | Cap 25 mg | Novatretin | 2384175 | Jul 2024 to 2026 |
| PSS | Adalimumab (Amgevita) | Inj 20 mg per 0.4 ml prefilled syringe | Amgevita | 2631121 | Oct 2022 to 31~Jul~2026 |
| PSS | Adalimumab (Amgevita) | Inj 40 mg per 0.8 ml prefilled pen | Amgevita | 2631105 | Oct 2022 to 31~Jul~2026 |
| PSS | Adalimumab (Amgevita) | Inj 40 mg per 0.8 ml prefilled syringe | Amgevita | 2631113 | Oct 2022 to 31~Jul~2026 |
| PSS | Adenosine | Inj 3 mg per ml, 10 ml vial | Adenosine Baxter | 2655780 | Dec 2024 to 2027 |
| PSS | Adenosine | Inj 3 mg per ml, 2 ml vial | Adsine | 2655799 | Dec 2024 to 2027 |
| PSS | Adrenaline | Inj 0.15 mg per 0.3 ml auto-injector | Epipen Jr | 208191 | Dec 2025 to 2028 |
| PSS | Adrenaline | Inj 0.3 mg per 0.3 ml auto-injector | Epipen | 223972 | Dec 2025 to 2028 |
| PSS | Alendronate sodium | Tab 70 mg | Fosamax | 2022133 | Jul 2024 to 2026 |
| PSS | Alendronate sodium with colecalciferol | Tab 70 mg with colecalciferol 5,600 iu | Fosamax Plus | 2337053 | Jul 2024 to 2026 |
| PSS | Alfentanil | Inj 0.5 mg per ml, 2 ml ampoule | Medsurge | 2650991 | Feb 2024 to 2026 |
| PSS | Allopurinol | Tab 100 mg | Ipca-Allopurinol | 2666855 | Jun 2024 to 2026 |
| PSS | Allopurinol | Tab 300 mg | Ipca-Allopurinol | 2666863 | Jun 2024 to 2026 |
| PSS | Ambrisentan | Tab 10 mg | Ambrisentan Viatris | 2626454 | Dec 2023 to 2026 |
| PSS | Ambrisentan | Tab 5 mg | Ambrisentan Viatris | 2626446 | Dec 2023 to 2026 |
| PSS | Amikacin | Inj 250 mg per ml, 2 ml vial | DBL Amikacin | 2572214 | Dec 2024 to 2027 |
| PSS | Amisulpride | Tab 100 mg | Sulprix | 2609401 | Dec 2024 to 2027 |
| PSS | Amisulpride | Tab 200 mg | Sulprix | 2609398 | Dec 2024 to 2027 |
| PSS | Amisulpride | Tab 400 mg | Sulprix | 2609428 | Dec 2024 to 2027 |
| PSS | Amitriptyline | Tab 10 mg | Arrow-Amitriptyline | 2404451 | Mar 2024 to 2026 |
| PSS | Amitriptyline | Tab 25 mg | Arrow-Amitriptyline | 2461250 | Mar 2024 to 2026 |
| PSS | Amitriptyline | Tab 50 mg | Arrow-Amitriptyline | 2461269 | Mar 2024 to 2026 |
| PSS | Amlodipine | Tab 10 mg | Vasorex | 2592525 | Feb 2024 to 2026 |
| PSS | Amlodipine | Tab 2.5 mg | Vasorex | 2592509 | Feb 2024 to 2026 |
| PSS | Amlodipine | Tab 5 mg | Vasorex | 2592517 | Feb 2024 to 2026 |
| PSS | Amorolfine | Nail soln 5% | MycoNail | 2461633 | Feb 2024 to 2026 |
| PSS | Amoxicillin | Grans for oral liq 125 mg per 5 ml | Alphamox 125 | 2503557 | Feb 2024 to 2026 |
| PSS | Amoxicillin | Grans for oral liq 250 mg per 5 ml | Alphamox 250 | 2503565 | Feb 2024 to 2026 |
| PSS | Amoxicillin with clavulanic acid | Inj 1,000 mg with clavulanic acid 200 mg vial | Synermox | 2431580 | Sep 2025 to 2027 |
| PSS | Amoxicillin with clavulanic acid | Inj 500 mg with clavulanic acid 100 mg vial | Synermox | 2431572 | Sep 2025 to 2027 |
| PSS | Amoxicillin with clavulanic acid | Grans for oral liq 25 mg with clavulanic acid 6.25 mg per ml | Augmentin | 319473 | May 2025 to 2027 |
| PSS | Amoxicillin with clavulanic acid | Grans for oral liq 50 mg with clavulanic acid 12.5 mg per ml | Amoxiclav Devatis Forte | 2684748 | Jun 2025 to 2027 |
| PSS | Amoxicillin with clavulanic acid | Tab 500 mg with clavulanic acid 125 mg | Curam Duo 500/125 | 2602121 | Feb 2024 to 2026 |
| PSS | Anastrozole | Tab 1 mg | Anatrole | 2520079 | Dec 2023 to 2026 |
| PSS | Aprepitant | Cap 2 x 80 mg and 1 x 125 mg | Emend Tri-Pack | 2244098 | Jan 2025 to 2027 |
| PSS | Aqueous cream | Crm 100 g | Evara | 2682303 | Mar 2025 to 2027 |
| PSS | Aqueous cream | Crm 500 g | Evara | 2555115 | Mar 2025 to 2027 |
| PSS | Aspirin | Tab dispersible 300 mg | Ethics Aspirin | 2184338 | May 2024 to 2026 |
| PSS | Aspirin | Tab 100 mg | Ethics Aspirin EC | 2184281 | Jun 2024 to 2026 |
| PSS | Aspirin | Tab 100 mg | Ethics Aspirin EC | 2213621 | Jun 2024 to 2026 |
| PSS | Atenolol | Tab 100 mg | Atenolol Viatris | 2627159 | Feb 2025 to 2027 |
| PSS | Atenolol | Tab 50 mg | Viatris | 2627140 | Feb 2025 to 2027 |
| PSS | Atomoxetine | Cap 10 mg | APO-Atomoxetine | 2638517 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 100 mg | APO-Atomoxetine | 2638541 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 18 mg | APO-Atomoxetine | 2637065 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 25 mg | APO-Atomoxetine | 2637073 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 40 mg | APO-Atomoxetine | 2637081 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 60 mg | APO-Atomoxetine | 2638525 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 80 mg | APO-Atomoxetine | 2638533 | Aug 2024 to 2026 |
| PSS | Atorvastatin | Tab 10 mg | Lorstat | 2493586 | Dec 2024 to 2027 |
| PSS | Atorvastatin | Tab 10 mg | Lorstat | 2697580 | Dec 2024 to 2027 |
| PSS | Atorvastatin | Tab 20 mg | Lorstat | 2493594 | Dec 2024 to 2027 |
| PSS | Atorvastatin | Tab 40 mg | Lorstat | 2493608 | Dec 2024 to 2027 |
| PSS | Atorvastatin | Tab 80 mg | Lorstat | 2493616 | Dec 2024 to 2027 |
| PSS | Atorvastatin | Tab 80 mg | Lorstat | 2697599 | Dec 2024 to 2027 |
| PSS | Atracurium besylate | Inj 10 mg per ml, 2.5 ml ampoule | Medsurge | 2688107 | Jun 2025 to 2026 |
| PSS | Atracurium besylate | Inj 10 mg per ml, 5 ml ampoule | Medsurge | 2688115 | Jun 2025 to 2026 |
| PSS | Atropine sulphate | Inj 600 mcg per ml, 1 ml ampoule | Martindale | 2528754 | Feb 2025 to 2027 |
| PSS | Atropine sulphate | Eye drops 1% | Atropt | 200905 | Feb 2024 to 2026 |
| PSS | Azacitidine | Inj 100 mg vial | Azacitidine Dr Reddy's | 2550083 | Mar 2025 to 2027 |
| PSS | Bacillus calmette-guerin vaccine | Inj Mycobacterium bovis BCG (Bacillus Calmette-Guerin), Danish strain 1331, live attenuated, vial with diluent | BCG Vaccine AJV | 2461854 | Dec 2024 to 2027 |
| PSS | Baclofen | Inj 2 mg per ml, 5 ml ampoule | Sintetica Baclofen Intrathecal | 2688417 | Mar 2025 to 2027 |
| PSS | Baclofen | Tab 10 mg | Pacifen | 403903 | Dec 2024 to 2027 |
| PSS | Bendamustine hydrochloride | Inj 100 mg vial | Bendamustine Sandoz | 2691442 | Apr 2025 to 2027 |
| PSS | Bendamustine hydrochloride | Inj 25 mg vial | Bendamustine Sandoz | 2691434 | Apr 2025 to 2027 |
| PSS | Bendroflumethiazide [Bendrofluazide] | Tab 2.5 mg | Arrow-Bendrofluazide | 2351420 | Mar 2024 to 2026 |
| PSS | Bendroflumethiazide [Bendrofluazide] | Tab 5 mg | Arrow-Bendrofluazide | 2351439 | Mar 2024 to 2026 |
| PSS | Benzylpenicillin sodium [Penicillin G] | Inj 600 mg (1 million units) vial | Sandoz | 433748 | Feb 2024 to 2026 |
| PSS | Betahistine dihydrochloride | Tab 16 mg | Serc | 2611376 | Dec 2023 to 2026 |
| PSS | Betamethasone dipropionate | Crm 0.05% | Diprosone | 210870 | Jul 2024 to 2026 |
| PSS | Betamethasone dipropionate | Oint 0.05% | Diprosone | 210897 | Jul 2024 to 2026 |
| PSS | Betamethasone dipropionate with calcipotriol | Oint 500 mcg with calcipotriol 50 mcg per g | Daivobet | 2170914 | Dec 2024 to 2027 |
| PSS | Betamethasone dipropionate with calcipotriol | Gel 500 mcg with calcipotriol 50 mcg per g | Daivobet | 2553015 | Dec 2024 to 2027 |
| PSS | Betamethasone valerate | Crm 0.1% | Beta Cream | 2188740 | Feb 2025 to 2027 |
| PSS | Betamethasone valerate | Oint 0.1% | Beta Ointment | 2188759 | Feb 2025 to 2027 |
| PSS | Betamethasone valerate | Lotn 0.1% | Betnovate | 210110 | May 2025 to 2027 |
| PSS | Betamethasone valerate | Scalp app 0.1% | Beta Scalp | 512877 | Feb 2025 to 2027 |
| PSS | Bevacizumab | Inj 25 mg per ml, 4 ml vial | Vegzelma | 2700700 | Aug 2025 to 31~Aug~2028 |
| PSS | Bevacizumab | Inj 25 mg per ml, 16 ml vial | Vegzelma | 2700719 | Aug 2025 to 31~Aug~2028 |
| PSS | Bezafibrate | Tab 200 mg | Bezalip | 474223 | Mar 2025 to 2027 |
| PSS | Bezafibrate | Tab long-acting 400 mg | Bezalip Retard | 354333 | Mar 2025 to 2027 |
| PSS | Bicalutamide | Tab 50 mg | Binarex | 2523655 | Dec 2023 to 2026 |
| PSS | Bimatoprost | Eye drops 0.03% | Lumigan | 2109220 | Jan 2025 to 2027 |
| PSS | Bisacodyl | Suppos 10 mg | Lax-Suppositories | 2485397 | Feb 2025 to 2027 |
| PSS | Bisoprolol fumarate | Tab 10 mg | Ipca-Bisoprolol | 2660377 | Apr 2024 to 2026 |
| PSS | Bisoprolol fumarate | Tab 2.5 mg | Ipca-Bisoprolol | 2660350 | Apr 2024 to 2026 |
| PSS | Bisoprolol fumarate | Tab 5 mg | Ipca-Bisoprolol | 2660369 | Apr 2024 to 2026 |
| PSS | Bosentan | Tab 125 mg | Bosentan Dr Reddy's | 2550075 | Jan 2025 to 2027 |
| PSS | Bosentan | Tab 62.5 mg | Bosentan Dr Reddy's | 2550067 | Jan 2025 to 2027 |
| PSS | Brimonidine tartrate | Eye drops 0.2% | Arrow-Brimonidine | 2396513 | Mar 2025 to 2027 |
| PSS | Brimonidine tartrate with timolol maleate | Eye drops 0.2% with timolol 0.5% | Combigan | 2203502 | Dec 2024 to 2027 |
| PSS | Brinzolamide | Eye drops 1% | Azopt | 2117061 | Dec 2024 to 2027 |
| PSS | Budesonide | Cap modified-release 3 mg | Budesonide Te Arai | 2661454 | Dec 2025 to 2028 |
| PSS | Budesonide | Nasal spray 100 mcg per dose | SteroClear | 2541068 | Feb 2025 to 2027 |
| PSS | Budesonide | Nasal spray 50 mcg per dose | SteroClear | 2541149 | Feb 2025 to 2027 |
| PSS | Bupivacaine hydrochloride | Inj 5 mg per ml, 4 ml ampoule | Marcain Isobaric | 2209284 | Feb 2024 to 2026 |
| PSS | Bupivacaine hydrochloride | Inj 2.5 mg per ml, 20 ml ampoule sterile pack | Marcain | 728071 | Feb 2024 to 2026 |
| PSS | Bupivacaine hydrochloride with glucose | Inj 0.5% with glucose 8%, 4 ml ampoule | Marcain Heavy | 2184435 | Dec 2025 to 2028 |
| PSS | Bupropion hydrochloride | Tab modified-release 150 mg | Zyban | 2439743 | May 2024 to 2026 |
| PSS | Buspirone hydrochloride | Tab 10 mg | Buspirone Viatris | 2615363 | Dec 2024 to 2027 |
| PSS | Buspirone hydrochloride | Tab 5 mg | Buspirone Viatris | 2615355 | Dec 2024 to 2027 |
| PSS | Calamine | Crm, aqueous, BP | healthE Calamine Aqueous | 2318628 | Apr 2025 to 2027 |
| PSS | Calcium carbonate | Tab 1.25 g (500 mg elemental) | Calci-Tab 500 | 2212269 | Feb 2024 to 2026 |
| PSS | Candesartan cilexetil | Tab 16 mg | Candestar | 2380420 | Feb 2025 to 2027 |
| PSS | Candesartan cilexetil | Tab 32 mg | Candestar | 2380439 | Feb 2025 to 2027 |
| PSS | Candesartan cilexetil | Tab 4 mg | Candestar | 2380404 | Feb 2025 to 2027 |
| PSS | Candesartan cilexetil | Tab 8 mg | Candestar | 2380412 | Feb 2025 to 2027 |
| PSS | Captopril | Oral liq 5 mg per ml | DP-Captopril | 2657775 | Apr 2024 to 2026 |
| PSS | Carbimazole | Tab 5 mg | Neo-Mercazole | 594423 | Dec 2025 to 2028 |
| PSS | Carboplatin | Inj 10 mg per ml, 45 ml vial | Carboplatin Accord | 2678926 | Dec 2024 to 2027 |
| PSS | Cefazolin | Inj 1 g vial | Cefazolin-AFT | 2391317 | Mar 2024 to 2026 |
| PSS | Cefazolin | Inj 2 g vial | Cefazolin-AFT | 2662876 | Mar 2024 to 2026 |
| PSS | Cefazolin | Inj 500 mg vial | Cefazolin-AFT | 2391325 | Mar 2024 to 2026 |
| PSS | Cefepime | Inj 1 g vial | Cefepime-AFT | 2437066 | Dec 2024 to 2027 |
| PSS | Cefepime | Inj 2 g vial | Cefepime-AFT | 2437074 | Dec 2024 to 2027 |
| PSS | Cefotaxime | Inj 1 g vial | DBL Cefotaxime | 2389762 | Dec 2023 to 2026 |
| PSS | Ceftazidime | Inj 1 g vial | Ceftazidime Kabi | 2581183 | Dec 2023 to 2026 |
| PSS | Cefuroxime | Inj 1.5 g vial | Cefuroxime Devatis | 2664909 | Jun 2024 to 2026 |
| PSS | Cefuroxime | Inj 750 mg vial | Cefuroxime Devatis | 2664895 | Jun 2024 to 2026 |
| PSS | Cetirizine hydrochloride | Tab 10 mg | Zista | 2500728 | Sep 2023 to 2026 |
| PSS | Cetomacrogol | Crm BP, 100 g | Cetomacrogol Cream AFT | 2696673 | Jun 2025 to 2027 |
| PSS | Cetomacrogol | Crm BP, 500 g | Cetomacrogol-AFT | 2615509 | Feb 2025 to 2027 |
| PSS | Cetomacrogol with glycerol | Crm 90% with glycerol 10% | Evara | 2702886 | Dec 2025 to 2028 |
| PSS | Cetomacrogol with glycerol | Crm 90% with glycerol 10% | Evara | 2702894 | Dec 2025 to 2028 |
| PSS | Chlorhexidine gluconate | Mouthwash 0.2% | healthE | 2393840 | Jan 2025 to 2027 |
| PSS | Chlorhexidine with cetrimide | Irrigation soln 0.015% with cetrimide 0.15%, 30 ml ampoule | LumaCina | 2700239 | Sep 2025 to 2028 |
| PSS | Cinacalcet | Tab 30 mg | Cinacalet Devatis | 2615517 | Dec 2024 to 2027 |
| PSS | Cinacalcet | Tab 60 mg | Cinacalet Devatis | 2615525 | Dec 2024 to 2027 |
| PSS | Ciprofloxacin | Eye drops 0.3% | Ciprofloxacin Teva | 2539144 | Mar 2025 to 2027 |
| PSS | Ciprofloxacin | Tab 250 mg | Ipca-Ciprofloxacin | 2676877 | Nov 2024 to 2026 |
| PSS | Ciprofloxacin | Tab 500 mg | Ipca-Ciprofloxacin | 2676885 | Nov 2024 to 2026 |
| PSS | Ciprofloxacin | Tab 750 mg | Ipca-Ciprofloxacin | 2676893 | Dec 2024 to 2026 |
| PSS | Cisplatin | Inj 1 mg per ml, 100 ml vial | Cisplatin Accord | 2682648 | Dec 2024 to 2027 |
| PSS | Clarithromycin | Inj 500 mg vial | Klacid IV | 2651904 | Jul 2024 to 2026 |
| HSS | Clarithromycin | Tab 250 mg | Klacid | 2606038 | Feb 2022 to 2027 |
| HSS | Clarithromycin | Tab 500 mg | Klacid | 2605295 | Feb 2022 to 2027 |
| PSS | Clindamycin | Cap 150 mg | Dalacin C | 2576392 | Dec 2024 to 2027 |
| PSS | Clomipramine hydrochloride | Tab 25 mg | APO Clomipramine | 2565773 | Jul 2025 to 2027 |
| PSS | Clonidine | Patch 2.5 mg, 100 mcg per day | Mylan | 2523078 | Feb 2024 to 2026 |
| PSS | Clonidine | Patch 5 mg, 200 mcg per day | Mylan | 2523086 | Feb 2024 to 2026 |
| PSS | Clonidine | Patch 7.5 mg, 300 mcg per day | Mylan | 2523094 | Feb 2024 to 2026 |
| PSS | Clonidine hydrochloride | Inj 150 mcg per ml, 1 ml ampoule | Catapres | 202266 | Jan 2025 to 2027 |
| PSS | Clonidine hydrochloride | Tab 150 mcg | Catapres | 202274 | Feb 2025 to 2027 |
| PSS | Clopidogrel | Tab 75 mg | Arrow - Clopid | 2648954 | Dec 2025 to 2028 |
| PSS | Codeine phosphate | Tab 15 mg | Noumed | 2643200 | Dec 2025 to 2028 |
| PSS | Codeine phosphate | Tab 30 mg | Noumed | 2643219 | Dec 2025 to 2028 |
| PSS | Codeine phosphate | Tab 60 mg | Noumed | 2643227 | Dec 2025 to 2028 |
| PSS | Colecalciferol | Cap 1.25 mg (50,000 iu) | Vit.D3 | 2523590 | Jun 2024 to 2026 |
| PSS | Compound electrolytes | Powder for oral soln | Electral | 2576937 | Dec 2025 to 2028 |
| PSS | Crotamiton | Crm 10% | Itch-Soothe | 2343614 | Feb 2025 to 2027 |
| PSS | Cyclizine hydrochloride | Tab 50 mg | Nausicalm | 2231220 | Feb 2025 to 2027 |
| PSS | Cyclophosphamide | Inj 1 g vial | Endoxan | 2034212 | Feb 2025 to 2027 |
| PSS | Cyclophosphamide | Inj 2 g vial | Endoxan | 2034220 | Feb 2025 to 2027 |
| PSS | Cyclophosphamide | Tab 50 mg | Cyclonex | 2611597 | Dec 2024 to 2027 |
| PSS | Cyproterone acetate | Tab 100 mg | Siterone | 2235862 | Jul 2025 to 2027 |
| PSS | Cyproterone acetate | Tab 50 mg | Siterone | 2220482 | Jul 2025 to 2027 |
| PSS | Cyproterone acetate with ethinyloestradiol | Tab 2 mg with ethinyloestradiol 35 mcg and 7 inert tablets | Ginet | 2455455 | Feb 2024 to 2026 |
| PSS | Dabigatran | Cap 110 mg | Pradaxa | 2319594 | Jul 2024 to 2026 |
| PSS | Dabigatran | Cap 150 mg | Pradaxa | 2389673 | Jul 2024 to 2026 |
| PSS | Dabigatran | Cap 75 mg | Pradaxa | 2319586 | Jul 2024 to 2026 |
| PSS | Darunavir | Tab 400 mg | Darunavir Viatris | 2626462 | Feb 2024 to 2026 |
| PSS | Darunavir | Tab 600 mg | Darunavir Viatris | 2626470 | Feb 2024 to 2026 |
| PSS | Dasatinib | Tab 20 mg | Dasatinib-Teva | 2679612 | Mar 2025 to 2027 |
| PSS | Dasatinib | Tab 50 mg | Dasatinib-Teva | 2679620 | Mar 2025 to 2027 |
| PSS | Dasatinib | Tab 70 mg | Dasatinib-Teva | 2679639 | Mar 2025 to 2027 |
| PSS | Desmopressin acetate | Nasal spray 10 mcg per dose, 6 ml | Desmopressin-PH&T | 2702916 | Apr 2025 to 2026 |
| PSS | Dexamethasone | Tab 0.5 mg | Dexmethsone | 2490218 | Feb 2025 to 2027 |
| PSS | Dexamethasone | Tab 4 mg | Dexmethsone | 2490226 | Feb 2025 to 2027 |
| PSS | Dexmedetomidine | Inj 100 mcg per ml, 2 ml vial | Dexmedetomidine Viatris | 2660008 | May 2024 to 2026 |
| PSS | Dexmedetomidine | Inj 100 mcg per ml, 2 ml vial | Dexmedetomidine Viatris | 2696258 | May 2024 to 2026 |
| PSS | Diazepam | Tab 2 mg | Arrow-Diazepam | 2327996 | Mar 2024 to 2026 |
| PSS | Diazepam | Tab 5 mg | Arrow-Diazepam | 2328003 | Mar 2024 to 2026 |
| PSS | Diclofenac sodium | Eye drops 0.1%, single dose | Diclofenac Devatis | 2694352 | Jul 2025 to 2027 |
| PSS | Diclofenac sodium | Eye drops 0.1%, single dose | Diclofenac Devatis | 2694360 | Jul 2025 to 2027 |
| PSS | Diclofenac sodium | Tab EC 25 mg | Diclofenac Sandoz | 2355981 | Feb 2025 to 2027 |
| PSS | Diclofenac sodium | Tab EC 50 mg | Diclofenac Sandoz | 2356007 | Feb 2025 to 2027 |
| PSS | Diclofenac sodium | Tab long-acting 75 mg | Voltaren SR | 2140276 | Aug 2025 to 2028 |
| PSS | Diltiazem hydrochloride | Cap long-acting 120 mg | Diltiazem CD Clinect | 2648172 | Dec 2025 to 2028 |
| HSS | Diltiazem hydrochloride | Cap long-acting 180 mg | Cardizem CD | 254584 | Mar 2022 to 2027 |
| HSS | Diltiazem hydrochloride | Cap long-acting 240 mg | Cardizem CD | 254592 | Mar 2022 to 2027 |
| PSS | Diphtheria, tetanus and pertussis vaccine | Inj 2 IU diphtheria toxoid with 20 IU tetanus toxoid, 8 mcg pertussis toxoid, 8 mcg pertussis filamentous haemagglutinin and 2.5 mcg pertactin in 0.5 ml prefilled syringe | Boostrix | 2459418 | Dec 2024 to 2027 |
| PSS | Diphtheria, tetanus, pertussis and polio vaccine | Inj 30 IU diphtheria toxoid with 30IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagglutinin, 8 mcg pertactin and 80 D-antigen units poliomyelitis virus in 0.5 ml syringe | Infanrix IPV | 2086417 | Dec 2024 to 2027 |
| PSS | Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine | Inj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe | Infanrix-hexa | 2459396 | Dec 2024 to 2027 |
| PSS | Dobutamine | Inj 12.5 mg per ml, 20 ml ampoule | Dobutamine-hameln | 2450836 | Dec 2024 to 2027 |
| PSS | Docetaxel | Inj 10 mg per ml, 8 ml vial | DBL Docetaxel | 2440830 | Dec 2023 to 2026 |
| PSS | Docusate sodium | Tab 120 mg | Coloxyl | 252859 | Feb 2024 to 2026 |
| PSS | Docusate sodium | Tab 50 mg | Coloxyl | 252832 | Feb 2024 to 2026 |
| PSS | Domperidone | Tab 10 mg | Domperidone Viatris | 2631903 | Dec 2025 to 2028 |
| PSS | Donepezil hydrochloride | Tab 10 mg | Ipca-Donepezil | 2666898 | Jun 2024 to 2026 |
| PSS | Donepezil hydrochloride | Tab 5 mg | Ipca-Donepezil | 2666871 | Jun 2024 to 2026 |
| PSS | Dopamine hydrochloride | Inj 40 mg per ml, 5 ml ampoule | Max Health Ltd | 2374374 | Feb 2025 to 2027 |
| PSS | Dorzolamide with timolol | Eye drops 2% with timolol 0.5% | Dortimopt | 2398354 | Feb 2025 to 2027 |
| PSS | Econazole nitrate | Crm 1% | Pevaryl | 2165953 | Jun 2025 to 2027 |
| PSS | Emtricitabine with tenofovir disoproxil | Tab 200 mg with tenofovir disoproxil 245 mg (300 mg as a maleate) | Tenofovir Disoproxil Emtricitabine Viatr | 2638088 | Dec 2025 to 2028 |
| PSS | Emulsifying ointment | Oint BP | Jaychem | 2377675 | Feb 2024 to 2026 |
| PSS | Emulsifying ointment | Oint BP, 500 g | Emulsifying Ointment ADE | 2597535 | May 2024 to 2026 |
| PSS | Enoxaparin sodium | Inj 100 mg in 1 ml syringe | Clexane | 2581906 | Feb 2025 to 2027 |
| PSS | Enoxaparin sodium | Inj 120 mg in 0.8 ml syringe | Clexane Forte | 2581914 | Feb 2025 to 2027 |
| PSS | Enoxaparin sodium | Inj 150 mg in 1 ml syringe | Clexane Forte | 2581922 | Feb 2025 to 2027 |
| PSS | Enoxaparin sodium | Inj 20 mg in 0.2 ml syringe | Clexane | 2581868 | Feb 2025 to 2027 |
| PSS | Enoxaparin sodium | Inj 40 mg in 0.4 ml syringe | Clexane | 2581876 | Feb 2025 to 2027 |
| PSS | Enoxaparin sodium | Inj 60 mg in 0.6 ml syringe | Clexane | 2581884 | Feb 2025 to 2027 |
| PSS | Enoxaparin sodium | Inj 80 mg in 0.8 ml syringe | Clexane | 2581892 | Feb 2025 to 2027 |
| PSS | Entacapone | Tab 200 mg | Entacapone Viatris | 2685299 | Jul 2025 to 2027 |
| PSS | Entecavir | Tab 0.5 mg | Entecavir (Rex) | 2654431 | Mar 2024 to 2026 |
| PSS | Ephedrine | Inj 3 mg per ml, 10 ml syringe | Ephedrine Juno | 2544598 | Jun 2024 to 2026 |
| PSS | Ephedrine | Inj 30 mg per ml, 1 ml ampoule | Max Health | 2402874 | Feb 2024 to 2026 |
| PSS | Eplerenone | Tab 25 mg | Inspra | 2619512 | Dec 2024 to 2027 |
| PSS | Eplerenone | Tab 50 mg | Inspra | 2619520 | Dec 2024 to 2027 |
| PSS | Erlotinib | Tab 100 mg | Alchemy | 2641569 | Oct 2024 to 2027 |
| PSS | Erlotinib | Tab 150 mg | Alchemy | 2641550 | Oct 2024 to 2027 |
| PSS | Erythromycin (as lactobionate) | Inj 1 g vial | Erythrocin IV | 2270234 | Dec 2025 to 2028 |
| PSS | Escitalopram | Tab 10 mg | Ipca-Escitalopram | 2661640 | Apr 2024 to 2026 |
| PSS | Escitalopram | Tab 20 mg | Ipca-Escitalopram | 2661659 | Apr 2024 to 2026 |
| PSS | Exemestane | Tab 25 mg | Pfizer Exemestane | 2500647 | Nov 2023 to 2026 |
| PSS | Ezetimibe | Tab 10 mg | Ezetimibe Sandoz | 2545861 | Dec 2023 to 2026 |
| PSS | Febuxostat | Tab 120 mg | Febuxostat (Teva) | 2670364 | Jun 2024 to 2026 |
| PSS | Febuxostat | Tab 80 mg | Febuxostat (Teva) | 2670356 | Jun 2024 to 2026 |
| PSS | Felodipine | Tab long-acting 2.5 mg | Plendil ER | 353760 | Feb 2025 to 2027 |
| PSS | Felodipine | Tab long-acting 10 mg | Felo 10 ER | 2041499 | Feb 2025 to 2027 |
| PSS | Felodipine | Tab long-acting 5 mg | Felo 5 ER | 2041510 | Feb 2025 to 2027 |
| PSS | Fentanyl | Inj 10 mcg per ml, 10 ml syringe | Biomed Fentanyl | 2670690 | Feb 2025 to 2027 |
| PSS | Fentanyl | Inj 50 mcg per ml, 2 ml ampoule | Boucher and Muir | 2381176 | May 2025 to 2027 |
| PSS | Fentanyl | Inj 10 mcg per ml, 100 ml bag | Biomed | 2594137 | Feb 2024 to 2026 |
| PSS | Fentanyl | Inj 20 mcg per ml, 50 ml syringe | Biomed | 2670704 | Feb 2025 to 2027 |
| PSS | Fentanyl | Inj 50 mcg per ml, 10 ml ampoule | Boucher and Muir | 2381168 | May 2025 to 2027 |
| PSS | Fentanyl | Patch 100 mcg per hour | Fentanyl Sandoz | 2472910 | Dec 2024 to 2027 |
| PSS | Fentanyl | Patch 12 mcg per hour | Fentanyl Sandoz | 2688824 | May 2025 to 2027 |
| PSS | Fentanyl | Patch 25 mcg per hour | Fentanyl Sandoz | 2472880 | Dec 2024 to 2027 |
| PSS | Fentanyl | Patch 50 mcg per hour | Fentanyl Sandoz | 2472899 | Dec 2024 to 2027 |
| PSS | Fentanyl | Patch 75 mcg per hour | Fentanyl Sandoz | 2472902 | Dec 2024 to 2027 |
| PSS | Ferrous fumarate | Tab 200 mg (65 mg elemental) | Ferro-tab | 2162156 | Feb 2025 to 2027 |
| PSS | Ferrous fumarate with folic acid | Tab 310 mg (100 mg elemental) with folic acid 350 mcg | Ferro-F-Tabs | 2615584 | Dec 2024 to 2027 |
| PSS | Fexofenadine hydrochloride | Tab 120 mg | Fexaclear | 2698781 | Jul 2025 to 2027 |
| PSS | Fexofenadine hydrochloride | Tab 180 mg | Fexaclear | 2697092 | Jul 2025 to 2027 |
| PSS | Filgrastim | Inj 300 mcg in 0.5 ml prefilled syringe | Nivestim | 2561956 | Dec 2024 to 2027 |
| PSS | Filgrastim | Inj 480 mcg in 0.5 ml prefilled syringe | Nivestim | 2561964 | Dec 2024 to 2027 |
| PSS | Finasteride | Tab 5 mg | Ricit | 2522756 | Dec 2023 to 2026 |
| PSS | Flecainide acetate | Cap long-acting 100 mg | Flecainide Controlled Release Teva | 2567113 | Aug 2023 to 2026 |
| PSS | Flecainide acetate | Cap long-acting 200 mg | Flecainide Controlled Release Teva | 2567121 | Aug 2023 to 2026 |
| PSS | Flecainide acetate | Tab 50 mg | Flecainide BNM | 2567695 | Dec 2023 to 2026 |
| PSS | Flucloxacillin | Cap 250 mg | Staphlex | 2139006 | Aug 2025 to 2027 |
| PSS | Flucloxacillin | Cap 500 mg | Staphlex | 2139014 | Aug 2025 to 2027 |
| PSS | Flucloxacillin | Inj 1 g vial | Flucil | 2523108 | Feb 2024 to 2026 |
| PSS | Flucloxacillin | Inj 250 mg vial | Flucloxin | 331848 | Jul 2024 to 2026 |
| PSS | Flucloxacillin | Inj 500 mg vial | Flucloxin | 331856 | Jul 2024 to 2026 |
| PSS | Flucloxacillin | Grans for oral liq 25 mg per ml | AFT | 2431424 | Feb 2025 to 2027 |
| PSS | Flucloxacillin | Grans for oral liq 50 mg per ml | AFT | 2431432 | Feb 2025 to 2027 |
| PSS | Fluconazole | Cap 150 mg | Mylan | 2149079 | Dec 2023 to 2026 |
| PSS | Fluconazole | Cap 200 mg | Mylan | 2149052 | Dec 2023 to 2026 |
| PSS | Fluconazole | Cap 50 mg | Mylan | 2149060 | Dec 2023 to 2026 |
| PSS | Fludrocortisone acetate | Tab 100 mcg | Florinef | 204951 | Dec 2025 to 2028 |
| PSS | Flumazenil | Inj 0.1 mg per ml, 5 ml ampoule | Flumazenil-Baxter | 2599481 | Dec 2024 to 2027 |
| PSS | Fluorouracil | Inj 50 mg per ml, 20 ml vial | Fluorouracil Accord | 2618435 | Dec 2024 to 2027 |
| PSS | Fluorouracil | Inj 50 mg per ml, 100 ml vial | Fluorouracil Accord | 2618427 | Dec 2024 to 2027 |
| PSS | Fluorouracil sodium | Crm 5% | Efudix | 253065 | Dec 2024 to 2027 |
| PSS | Fluticasone propionate | Metered dose nasal spray 50 mcg per dose | Flixonase Hayfever & Allergy | 2407000 | Feb 2026 to 2028 |
| HSS | Folic acid | Tab 5 mg | Folic Acid Viatris | 2633450 | Mar 2023 to 2027 |
| PSS | Fosfomycin | Powder for oral solution, 3 g sachet | UroFos | 2538210 | Apr 2025 to 2027 |
| PSS | Furosemide [Frusemide] | Tab 40 mg | IPCA-Frusemide | 2618699 | Feb 2025 to 2027 |
| HSS | Gabapentin | Cap 100 mg | Nupentin | 2422751 | Feb 2022 to 2027 |
| HSS | Gabapentin | Cap 300 mg | Nupentin | 2422778 | Feb 2022 to 2027 |
| HSS | Gabapentin | Cap 400 mg | Nupentin | 2422786 | Feb 2022 to 2027 |
| PSS | Gemcitabine Hydrochloride | Inj 43.3 mg per ml (equivalent to 38 mg per ml gemcitabine), 26.3 ml vial | DBL Gemcitabine | 2521423 | Jun 2024 to 2026 |
| PSS | Gliclazide | Tab 80 mg | Glizide | 2280647 | Feb 2024 to 2026 |
| PSS | Glipizide | Tab 5 mg | Minidiab | 2091755 | Mar 2025 to 2027 |
| PSS | Glucose [Dextrose] | Inj 50%, 10 ml ampoule | Biomed | 2243296 | Feb 2024 to 2026 |
| PSS | Glucose [Dextrose] | Inj 50%, 90 ml bottle | Biomed | 2245833 | Feb 2024 to 2026 |
| PSS | Goserelin | Implant 10.8 mg, syringe | Zoladex | 362107 | Apr 2024 to 2026 |
| PSS | Goserelin | Implant 3.6 mg, syringe | Zoladex | 678066 | Apr 2024 to 2026 |
| PSS | Granisetron | Inj 1 mg per ml, 3 ml ampoule | Deva | 2554186 | Feb 2024 to 2026 |
| PSS | Haemophilus influenzae type B vaccine | Inj 10 mcg vial with diluent syringe | Act-HIB | 2404699 | Dec 2024 to 2027 |
| PSS | Haemophilus influenzae type B vaccine | Inj 10 mcg vial with diluent syringe | Act-HIB | 2697955 | Dec 2024 to 2027 |
| PSS | Hepatitis A vaccine | Inj 1440 ELISA units in 1 ml syringe | Havrix 1440 | 2061937 | Dec 2024 to 2027 |
| PSS | Hepatitis A vaccine | Inj 720 ELISA units in 0.5 ml syringe | Havrix Junior | 793582 | Dec 2024 to 2027 |
| PSS | Hepatitis B recombinant vaccine | Inj 10 mcg per 0.5 ml prefilled syringe | Engerix-B | 2601044 | Dec 2024 to 2027 |
| PSS | Hepatitis B recombinant vaccine | Inj 20 mcg per 1 ml prefilled syringe | Engerix-B | 2534533 | Dec 2024 to 2027 |
| PSS | Human papillomavirus (6, 11, 16, 18, 31, 33, 45, 52 and 58) vaccine [HPV] | Inj 270 mcg in 0.5 ml syringe | Gardasil 9 | 2506254 | Dec 2024 to 2027 |
| PSS | Hydrocortisone | Inj 100 mg vial | Solu-Cortef | 265284 | Dec 2024 to 2027 |
| PSS | Hydrocortisone and paraffin liquid and lanolin | Lotn 1% with paraffin liquid 15.9% and lanolin 0.6% | DP Lotn HC | 716294 | Jun 2024 to 2026 |
| PSS | Hydrocortisone with miconazole | Crm 1% with miconazole nitrate 2% | Micreme H | 704733 | Feb 2025 to 2027 |
| PSS | Hydroxocobalamin | Inj 1 mg per ml, 1 ml ampoule | Hydroxocobalamin Panpharma | 2637391 | Jul 2025 to 2027 |
| PSS | Hydroxychloroquine sulphate | Tab 200 mg | Ipca-Hydroxychloroquine | 2690233 | May 2025 to 2027 |
| PSS | Hydroxyurea [hydroxycarbamide] | Cap 500 mg | Devatis | 2593246 | Dec 2023 to 2026 |
| PSS | Hyoscine butylbromide | Inj 20 mg, 1 ml ampoule | Spazmol | 2656027 | Dec 2023 to 2026 |
| PSS | Hyoscine butylbromide | Tab 10 mg | Hyoscine Butylbromide (Adiramedica) | 2687224 | Apr 2025 to 2027 |
| PSS | Ibuprofen | Oral liq 20 mg per ml | Ethics | 2551985 | Apr 2025 to 2027 |
| HSS | Ibuprofen | Tab 200 mg - 1,000 tablet pack | Relieve | 2526212 | Feb 2021 to 2026 |
| PSS | Ibuprofen | Tab long-acting 800 mg | Ibuprofen SR BNM | 2690276 | Apr 2025 to 2027 |
| PSS | Iloprost | Nebuliser soln 10 mcg per ml, 2 ml | Vebulis | 2643006 | Dec 2025 to 2028 |
| PSS | Imatinib mesilate | Cap 100 mg | Imatinib-Rex | 2594315 | Dec 2023 to 2026 |
| PSS | Imatinib mesilate | Cap 400 mg | Imatinib-Rex | 2594323 | Dec 2023 to 2026 |
| PSS | Indapamide | Tab 2.5 mg | Dapa-Tabs | 2356406 | Feb 2024 to 2026 |
| PSS | Isoniazid | Tab 100 mg | Noumed Isoniazid | 2695901 | May 2025 to 2027 |
| PSS | Isoniazid with rifampicin | Tab 100 mg with rifampicin 150 mg | Rifinah | 251232 | Feb 2025 to 2027 |
| PSS | Isoniazid with rifampicin | Tab 150 mg with rifampicin 300 mg | Rifinah | 251240 | Feb 2025 to 2027 |
| PSS | Isosorbide mononitrate | Tab 20 mg | Ismo 20 | 214833 | Feb 2024 to 2026 |
| PSS | Isosorbide mononitrate | Tab long-acting 40 mg | Ismo 40 Retard | 2447355 | Feb 2024 to 2026 |
| PSS | Isosorbide mononitrate | Tab long-acting 60 mg | Duride | 2202964 | Feb 2024 to 2026 |
| PSS | Isotretinoin | Cap 10 mg | Oratane | 2400286 | Dec 2024 to 2027 |
| PSS | Isotretinoin | Cap 20 mg | Oratane | 2400278 | Dec 2024 to 2027 |
| PSS | Isotretinoin | Cap 5 mg | Oratane | 2339161 | Dec 2024 to 2027 |
| PSS | Ispaghula (psyllium) husk | Powder for oral soln | Konsyl-D | 2358727 | Feb 2024 to 2026 |
| PSS | Ketoconazole | Shampoo 2% | Sebizole | 461504 | May 2024 to 2026 |
| PSS | Lamivudine | Tab 100 mg | Zetlam | 2399369 | Feb 2024 to 2026 |
| PSS | Lamivudine | Tab 150 mg | Lamivudine Viatris | 2638045 | Feb 2024 to 2026 |
| PSS | Lanreotide | Inj 120 mg per 0.5 ml, 0.5 ml syringe | Mytolac | 2698161 | Aug 2025 to 2027 |
| PSS | Lanreotide | Inj 60 mg per 0.5 ml, 0.5 ml syringe | Mytolac | 2698145 | Aug 2025 to 2027 |
| PSS | Lanreotide | Inj 60 mg per 0.5 ml, 0.5 ml syringe | Mytolac | 2709597 | Aug 2025 to 2027 |
| PSS | Lanreotide | Inj 90 mg per 0.5 ml, 0.5 ml syringe | Mytolac | 2698153 | Sep 2025 to 2027 |
| PSS | Lansoprazole | Cap 15 mg | Lanzol Relief | 2482533 | Feb 2025 to 2027 |
| PSS | Lansoprazole | Cap 30 mg | Lanzol Relief | 2482541 | Feb 2025 to 2027 |
| PSS | Latanoprost | Eye drops 0.005% | Teva | 2553139 | Mar 2025 to 2027 |
| PSS | Latanoprost with timolol | Eye drops 0.005% with timolol 0.5% | Arrow - Lattim | 2597861 | Mar 2024 to 2026 |
| PSS | Leflunomide | Tab 10 mg | Arava | 306843 | Dec 2023 to 2026 |
| PSS | Leflunomide | Tab 20 mg | Arava | 369470 | Dec 2023 to 2026 |
| PSS | Lenalidomide (Viatris) | Cap 10 mg | Lenalidomide Viatris | 2673533 | Feb 2025 to 31~Jan~2028 |
| PSS | Lenalidomide (Viatris) | Cap 15 mg | Lenalidomide Viatris | 2673541 | Feb 2025 to 31~Jan~2028 |
| PSS | Lenalidomide (Viatris) | Cap 25 mg | Lenalidomide Viatris | 2673568 | Feb 2025 to 31~Jan~2028 |
| PSS | Lenalidomide (Viatris) | Cap 5 mg | Lenalidomide Viatris | 2673525 | Feb 2025 to 31~Jan~2028 |
| PSS | Letrozole | Tab 2.5 mg | Letrole | 2656655 | Dec 2024 to 2027 |
| PSS | Levodopa with carbidopa | Tab 100 mg with carbidopa 25 mg | Sinemet | 2429985 | Feb 2025 to 2027 |
| PSS | Levodopa with carbidopa | Tab long-acting 200 mg with carbidopa 50 mg | Sinemet CR | 2430002 | Feb 2025 to 2027 |
| PSS | Levodopa with carbidopa | Tab 250 mg with carbidopa 25 mg | Sinemet | 2429993 | Feb 2025 to 2027 |
| PSS | Levodopa with carbidopa and entacapone | Tab 100 mg with carbidopa 25 mg and entacapone 200 mg | Stalevo | 2696541 | Jul 2025 to 2027 |
| PSS | Levodopa with carbidopa and entacapone | Tab 150 mg with carbidopa 37.5 mg and entacapone 200 mg | Stalevo | 2696568 | Jul 2025 to 2027 |
| PSS | Levodopa with carbidopa and entacapone | Tab 200 mg with carbidopa 50 mg and entacapone 200 mg | Stalevo | 2696576 | Jul 2025 to 2027 |
| PSS | Levodopa with carbidopa and entacapone | Tab 50 mg with carbidopa 12.5 mg and entacapone 200 mg | Stalevo | 2696533 | Jul 2025 to 2027 |
| PSS | Levomepromazine hydrochloride | Inj 25 mg per ml, 1 ml ampoule | Wockhardt | 2501902 | Dec 2025 to 2028 |
| PSS | Levonorgestrel | Subdermal implant (2 x 75 mg rods) | Jadelle | 2703068 | Apr 2025 to 2026 |
| PSS | Levosimendan | Inj 2.5 mg per ml, 5 ml vial | Simdax | 2304236 | Nov 2024 to 2027 |
| PSS | Lidocaine [Lignocaine] hydrochloride with adrenaline | Inj 1% with adrenaline 1:100,000, 5 ml ampoule | Xylocaine | 2120577 | Dec 2025 to 2028 |
| PSS | Linezolid | Inj 2 mg per ml, 300 ml bottle | Linezolid Kabi | 2556766 | Dec 2024 to 2027 |
| PSS | Linezolid | Tab 600 mg | Zyvox | 2058758 | Dec 2024 to 2027 |
| PSS | Lithium carbonate | Tab long-acting 400 mg | Priadel | 260851 | Feb 2025 to 2027 |
| PSS | Lopinavir with ritonavir | Tab 200 mg with ritonavir 50 mg | Lopinavir/Ritonavir Mylan | 2613549 | Feb 2025 to 2027 |
| PSS | Lorazepam | Tab 1 mg | Ativan | 2139022 | Feb 2025 to 2027 |
| PSS | Lorazepam | Tab 2.5 mg | Ativan | 250120 | Feb 2025 to 2027 |
| PSS | Losartan potassium | Tab 100 mg | Losartan Actavis | 2466880 | Mar 2024 to 2026 |
| PSS | Losartan potassium | Tab 12.5 mg | Losartan Actavis | 2466856 | Mar 2024 to 2026 |
| PSS | Losartan potassium | Tab 25 mg | Losartan Actavis | 2466864 | Mar 2024 to 2026 |
| PSS | Losartan potassium | Tab 50 mg | Losartan Actavis | 2466872 | Mar 2024 to 2026 |
| PSS | Macrogol 3350 with potassium chloride and sodium chloride | Powder for oral soln 755.68 mg with potassium chloride 10.55 mg, sodium chloride 37.33 mg and sodium sulphate 80.62 mg per g, 70 g sachet | Glycoprep Orange | 2637987 | Feb 2025 to 2027 |
| PSS | Macrogol 3350 with potassium chloride and sodium chloride | Powder for oral soln 755.68 mg with potassium chloride 10.55 mg, sodium chloride 37.33 mg and sodium sulphate 80.62 mg per g, 70 g sachet | Glycoprep Orange | 2637995 | Feb 2025 to 2027 |
| PSS | Macrogol 3350 with potassium chloride and sodium chloride with/without sodium sulfate, sodium ascorbate, ascorbic acid | Powd for oral soln 100g with potassium chloride 1g, sodium chloride 2g and sodium sulfate 9g per sach(1), powd for oral soln 40g with potassium chloride 1.2g and sodium chloride 3.2g per sach(1) and powd for oral soln ascorbic acid 7.54g and sodium ascorbate 48.11g per sach(1) | Plenvu | 2569671 | Oct 2023 to 2026 |
| PSS | Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride | Powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg | Molaxole | 2519887 | Feb 2024 to 2026 |
| PSS | Magnesium sulphate | Inj 2 mmol per ml, 5 ml ampoule | Martindale | 2406438 | Jun 2024 to 2026 |
| PSS | Measles, mumps and rubella vaccine | Injection, measles virus 1,000 CCID50, mumps virus 5,012 CCID50, Rubella virus 1,000 CCID50; prefilled syringe/ampoule of diluent 0.5 ml | Priorix | 2509369 | Dec 2024 to 2027 |
| PSS | Mebendazole | Tab 100 mg | Vermox | 258040 | Dec 2024 to 2027 |
| PSS | Mebeverine hydrochloride | Tab 135 mg | Colofac | 2535297 | Dec 2023 to 2026 |
| PSS | Melatonin | Tab modified-release 2 mg | Vigisom | 2612593 | Dec 2024 to 2027 |
| PSS | Melphalan | Inj 50 mg vial | Melpha | 2647699 | Dec 2023 to 2026 |
| PSS | Meningococcal (A, C, Y and W-135) conjugate vaccine | Inj 10 mcg of each meningococcal polysaccharide conjugated to a total of approximately 55 mcg of tetanus toxoid carrier per 0.5 ml vial | MenQuadfi | 2649012 | Dec 2024 to 2027 |
| PSS | Mercaptopurine | Tab 50 mg | Puri-nethol | 261270 | Dec 2025 to 2028 |
| PSS | Meropenem | Inj 1 g vial | Meropenem-AFT | 2591316 | Jun 2024 to 2026 |
| PSS | Meropenem | Inj 500 mg vial | Meropenem-AFT | 2591308 | Jun 2024 to 2026 |
| PSS | Metaraminol | Inj 10 mg per ml, 1 ml ampoule | Torbay | 2482983 | Feb 2024 to 2026 |
| HSS | Metformin hydrochloride | Tab immediate-release 500 mg | Metformin Viatris | 2628031 | Mar 2023 to 2027 |
| HSS | Metformin hydrochloride | Tab immediate-release 850 mg | Metformin Viatris | 2628058 | Aug 2023 to 2027 |
| PSS | Methadone hydrochloride | Oral liq 10 mg per ml | Biodone Extra Forte | 412325 | Feb 2025 to 2027 |
| PSS | Methadone hydrochloride | Oral liq 2 mg per ml | Biodone | 361372 | Feb 2025 to 2027 |
| PSS | Methadone hydrochloride | Oral liq 5 mg per ml | Biodone Forte | 412341 | Feb 2025 to 2027 |
| PSS | Methotrexate | Inj 10 mg prefilled syringe | Methotrexate Sandoz | 2445840 | Feb 2025 to 2027 |
| PSS | Methotrexate | Inj 15 mg prefilled syringe | Methotrexate Sandoz | 2445859 | Feb 2025 to 2027 |
| PSS | Methotrexate | Inj 20 mg prefilled syringe | Methotrexate Sandoz | 2445867 | Feb 2025 to 2027 |
| PSS | Methotrexate | Inj 25 mg prefilled syringe | Methotrexate Sandoz | 2445875 | Feb 2025 to 2027 |
| PSS | Methotrexate | Inj 30 mg prefilled syringe | Methotrexate Sandoz | 2445883 | Feb 2025 to 2027 |
| PSS | Methotrexate | Inj 100 mg per ml, 50 ml vial | Methotrexate Ebewe | 2215683 | Dec 2023 to 2026 |
| PSS | Methotrexate | Inj 7.5 mg prefilled syringe | Methotrexate Sandoz | 2445832 | Feb 2025 to 2027 |
| PSS | Methotrexate | Tab 10 mg | Trexate | 2537079 | Dec 2024 to 2027 |
| PSS | Methotrexate | Tab 2.5 mg | Trexate | 2537060 | Dec 2024 to 2027 |
| PSS | Methylprednisolone aceponate | Crm 0.1% | Advantan | 389439 | Feb 2024 to 2026 |
| PSS | Methylprednisolone aceponate | Oint 0.1% | Advantan | 388874 | Feb 2024 to 2026 |
| PSS | Metoclopramide hydrochloride | Tab 10 mg | Metoclopramide Actavis 10 | 2528878 | Mar 2024 to 2026 |
| PSS | Metoprolol succinate | Tab long-acting 190 mg | Myloc CR | 2650738 | Apr 2024 to 2026 |
| PSS | Metoprolol succinate | Tab long-acting 23.75 mg | Myloc CR | 2650681 | Apr 2024 to 2026 |
| PSS | Metoprolol succinate | Tab long-acting 47.5 mg | Myloc CR | 2650703 | Apr 2024 to 2026 |
| PSS | Metoprolol succinate | Tab long-acting 95 mg | Myloc CR | 2650711 | Apr 2024 to 2026 |
| HSS | Metoprolol tartrate | Tab 100 mg | IPCA-Metoprolol | 2618680 | Mar 2022 to 2027 |
| HSS | Metoprolol tartrate | Tab 50 mg | IPCA-Metoprolol | 2618672 | Mar 2022 to 2027 |
| PSS | Metronidazole | Inj 5 mg per ml, 100 ml bag | Baxter | 2548305 | Dec 2023 to 2026 |
| PSS | Metronidazole | Tab 200 mg | Metronidamed | 2684446 | Mar 2025 to 2027 |
| PSS | Metronidazole | Tab 400 mg | Metronidamed | 2684454 | Mar 2025 to 2027 |
| PSS | Miconazole | Oral gel 20 mg per g | Decozol | 2405008 | Feb 2025 to 2027 |
| PSS | Miconazole nitrate | Crm 2% | Multichem | 2184354 | May 2024 to 2026 |
| PSS | Midazolam | Inj 1 mg per ml, 5 ml ampoule | Midazolam-Baxter | 2599279 | May 2025 to 2027 |
| PSS | Midazolam | Inj 5 mg per ml, 3 ml ampoule | Midazolam-Baxter | 2599260 | May 2025 to 2027 |
| PSS | Midodrine | Tab 2.5 mg | Midodrine Medsurge | 2632063 | Feb 2025 to 2027 |
| PSS | Midodrine | Tab 5 mg | Midodrine Medsurge | 2632071 | Feb 2025 to 2027 |
| PSS | Milrinone | Inj 1 mg per ml, 10 ml ampoule | Milrinone-Baxter | 2603047 | Dec 2024 to 2027 |
| PSS | Moclobemide | Tab 150 mg | Aurorix | 2602385 | Feb 2025 to 2027 |
| PSS | Moclobemide | Tab 300 mg | Aurorix | 2602393 | Feb 2025 to 2027 |
| PSS | Modafinil | Tab 100 mg | Modafinil Max Health | 2690586 | May 2025 to 2027 |
| PSS | Mometasone furoate | Crm 0.1% | Elocon Alcohol Free | 218375 | Feb 2025 to 2027 |
| PSS | Mometasone furoate | Crm 0.1% | Elocon Alcohol Free | 2395738 | Feb 2025 to 2027 |
| PSS | Mometasone furoate | Oint 0.1% | Elocon | 218383 | Feb 2025 to 2027 |
| PSS | Mometasone furoate | Oint 0.1% | Elocon | 2395746 | Feb 2025 to 2027 |
| PSS | Mometasone furoate | Lotn 0.1% | Elocon | 2177633 | Feb 2025 to 2027 |
| PSS | Montelukast | Tab 10 mg | Montelukast Viatris | 2643634 | Dec 2025 to 2028 |
| PSS | Montelukast | Tab 4 mg | Montelukast Viatris | 2643618 | Dec 2025 to 2028 |
| PSS | Montelukast | Tab 5 mg | Montelukast Viatris | 2643626 | Dec 2025 to 2028 |
| PSS | Morphine sulphate | Inj 1 mg per ml, 100 ml bag | Biomed | 2526034 | Feb 2024 to 2026 |
| PSS | Morphine sulphate | Inj 1 mg per ml, 10 ml syringe | Biomed | 2526018 | Feb 2024 to 2026 |
| PSS | Morphine sulphate | Inj 1 mg per ml, 50 ml syringe | Biomed | 2526026 | Feb 2024 to 2026 |
| PSS | Moxifloxacin | Inj 1.6 mg per ml, 250 ml bottle | Moxifloxacin Kabi | 2577062 | Feb 2024 to 2026 |
| HSS | Nadolol | Tab 40 mg | Nadolol BNM | 2621118 | Mar 2022 to 2027 |
| HSS | Nadolol | Tab 40 mg | Nadolol BNM | 2647540 | Mar 2022 to 2027 |
| HSS | Nadolol | Tab 80 mg | Nadolol BNM | 2621126 | Mar 2022 to 2027 |
| HSS | Nadolol | Tab 80 mg | Nadolol BNM | 2647559 | Mar 2022 to 2027 |
| PSS | Naloxone hydrochloride | Inj 400 mcg per ml, 1 ml ampoule | DBL Naloxone Hydrochloride | 788457 | Apr 2025 to 2027 |
| PSS | Naltrexone hydrochloride | Tab 50 mg | Naltraccord | 2380374 | Dec 2023 to 2026 |
| PSS | Naphazoline hydrochloride | Eye drops 0.1% | Albalon | 200182 | Jan 2025 to 2027 |
| PSS | Naproxen | Tab long-acting 1 g | Naprosyn SR 1000 | 2518619 | Feb 2025 to 2027 |
| PSS | Naproxen | Tab 250 mg | Noflam 250 | 2654458 | Feb 2025 to 2027 |
| PSS | Naproxen | Tab 500 mg | Noflam 500 | 2654466 | Feb 2025 to 2027 |
| PSS | Naproxen | Tab long-acting 750 mg | Naprosyn SR 750 | 2518627 | Feb 2025 to 2027 |
| PSS | Neostigmine metilsulfate | Inj 2.5 mg per ml, 1 ml ampoule | Max Health | 2599996 | Feb 2025 to 2027 |
| PSS | Nevirapine | Tab 200 mg | Nevirapine Viatris | 2640023 | Feb 2025 to 2027 |
| PSS | Nitrofurantoin | Cap modified-release 100 mg | Macrobid | 2493624 | Dec 2023 to 2026 |
| PSS | Nitrofurantoin | Tab 50 mg | Nifuran | 254738 | Dec 2024 to 2027 |
| PSS | Nystatin | Vaginal crm 100,000 u per 5 g with applicator(s) | Nilstat | 254908 | Feb 2024 to 2026 |
| PSS | Nystatin | Oral liquid 100,000 u per ml | Nilstat | 254851 | Feb 2024 to 2026 |
| PSS | Octreotide Long-Acting | Inj depot 10 mg prefilled syringe | Sandostatin LAR | 2150832 | Dec 2024 to 2027 |
| PSS | Octreotide Long-Acting | Inj depot 20 mg prefilled syringe | Sandostatin LAR | 2150840 | Dec 2024 to 2027 |
| PSS | Octreotide Long-Acting | Inj depot 30 mg prefilled syringe | Sandostatin LAR | 2150859 | Dec 2024 to 2027 |
| PSS | Oestradiol | Gel (transdermal) 0.06% (750 mcg/actuation) | Estrogel | 2656191 | Nov 2024 to 31~Oct~2027 |
| PSS | Oestradiol | Patch 100 mcg per day | Estradiol TDP Mylan | 2661497 | Dec 2025 to 2027 |
| PSS | Oestradiol | Patch 25 mcg per day | Estradiol TDP Mylan | 2601583 | Dec 2025 to 2027 |
| PSS | Oestradiol | Patch 50 mcg per day | Estradiol TDP Mylan | 2601591 | Dec 2025 to 2027 |
| PSS | Oestradiol | Patch 75 mcg per day | Estradiol TDP Mylan | 2605317 | Dec 2025 to 2027 |
| PSS | Oestradiol valerate | Tab 1 mg | Progynova | 2450453 | Dec 2025 to 2028 |
| PSS | Oestradiol valerate | Tab 2 mg | Progynova | 2619423 | Dec 2025 to 2028 |
| PSS | Oestriol | Crm 1 mg per g with applicator | Ovestin | 767441 | Feb 2024 to 2026 |
| PSS | Oestriol | Pessaries 500 mcg | Ovestin | 767468 | Feb 2024 to 2026 |
| PSS | Oestriol | Tab 2 mg | Ovestin | 767476 | Feb 2024 to 2026 |
| PSS | Oil in water emulsion | Crm, 500 g | Fatty Emulsion Cream (Evara) | 2491311 | Apr 2025 to 2027 |
| PSS | Oil in water emulsion | Crm, 100 g | Fatty Emulsion Cream (Evara) | 2684497 | Apr 2025 to 2027 |
| PSS | Olanzapine | Tab 10 mg | Zypine | 2651092 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab orodispersible 10 mg | Zypine ODT | 2439840 | Feb 2024 to 2026 |
| PSS | Olanzapine | Tab 2.5 mg | Zypine | 2651076 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab 5 mg | Zypine | 2651084 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab orodispersible 5 mg | Zypine ODT | 2439832 | Feb 2024 to 2026 |
| PSS | Omeprazole | Cap 10 mg | Omeprazole actavis 10 | 2604930 | Mar 2024 to 2026 |
| PSS | Omeprazole | Cap 20 mg | Omeprazole actavis 20 | 2604949 | Mar 2024 to 2026 |
| PSS | Omeprazole | Cap 40 mg | Omeprazole actavis 40 | 2604957 | Mar 2024 to 2026 |
| PSS | Ondansetron | Tab 4 mg | Periset | 2648024 | Dec 2025 to 2028 |
| PSS | Ondansetron | Tab dispersible 4 mg | Periset ODT | 2656868 | Mar 2024 to 2026 |
| PSS | Ondansetron | Tab 8 mg | Periset | 2648032 | Dec 2025 to 2028 |
| PSS | Ondansetron | Tab dispersible 8 mg | Periset ODT | 2656876 | Mar 2024 to 2026 |
| PSS | Ornidazole | Tab 500 mg | Arrow-Ornidazole | 2385325 | Mar 2025 to 2027 |
| PSS | Orphenadrine citrate | Tab 100 mg | Norflex | 2645564 | Feb 2025 to 2027 |
| PSS | Oxycodone hydrochloride | Inj 10 mg per ml, 1 ml ampoule | Hameln | 2631172 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Inj 10 mg per ml, 2 ml ampoule | Hameln | 2631180 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Inj 50 mg per ml, 1 ml ampoule | Hameln | 2631199 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 10 mg | Oxycodone Sandoz | 2559722 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 20 mg | Oxycodone Sandoz | 2559730 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 40 mg | Oxycodone Sandoz | 2559749 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 5 mg | Oxycodone Sandoz | 2559714 | Dec 2024 to 2027 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 80 mg | Oxycodone Sandoz | 2559757 | Dec 2024 to 2027 |
| PSS | Paclitaxel | Inj 6 mg per ml, 16.7 ml vial | Anzatax | 2271834 | Aug 2024 to 2026 |
| PSS | Paclitaxel | Inj 6 mg per ml, 50 ml vial | Anzatax | 2271818 | Aug 2024 to 2026 |
| PSS | Paracetamol | Suppos 125 mg | Gacet | 2482711 | Feb 2024 to 2026 |
| PSS | Paracetamol | Suppos 250 mg | Gacet | 2482738 | Feb 2024 to 2026 |
| PSS | Paracetamol | Suppos 500 mg | Gacet | 2552663 | Feb 2024 to 2026 |
| HSS | Paracetamol | Tab 500 mg - blister pack - 1,000 tablet pack | Pacimol | 2612712 | Feb 2022 to 2026 |
| HSS | Paracetamol | Tab 500 mg - bottle pack | Noumed Paracetamol | 2611430 | Feb 2022 to 2026 |
| PSS | Paraffin | White soft, | EVARA White Soft Paraffin | 2664178 | Jun 2024 to 2026 |
| PSS | Parecoxib | Inj 40 mg vial | Dynastat | 2394804 | Dec 2024 to 2027 |
| PSS | Pazopanib | Tab 200 mg | Pazopanib Teva | 2695332 | May 2025 to 2027 |
| PSS | Pazopanib | Tab 400 mg | Pazopanib Teva | 2695340 | May 2025 to 2027 |
| PSS | Pemetrexed | Inj 100 mg vial | Pemetrexed-AFT | 2693917 | Apr 2025 to 2027 |
| PSS | Pemetrexed | Inj 500 mg vial | Pemetrexed-AFT | 2693925 | Apr 2025 to 2027 |
| PSS | Perindopril | Tab 2 mg | Coversyl | 2603942 | Dec 2024 to 2027 |
| PSS | Perindopril | Tab 4 mg | Coversyl | 2603950 | Dec 2024 to 2027 |
| PSS | Perindopril | Tab 8 mg | Coversyl | 2643316 | Dec 2024 to 2027 |
| PSS | Permethrin | Lotn 5% | A-Scabies | 2332027 | Feb 2024 to 2026 |
| PSS | Phenoxymethylpenicillin [Penicillin V] | Cap 250 mg | Cilicaine VK | 2602865 | Feb 2025 to 2027 |
| PSS | Phenoxymethylpenicillin [Penicillin V] | Cap 500 mg | Cilicaine VK | 2602873 | Feb 2025 to 2027 |
| PSS | Pimecrolimus | Crm 1% | Elidel | 2098873 | Feb 2024 to 2026 |
| PSS | Pine tar with trolamine laurilsulfate and fluorescein | Soln 2.3% with trolamine laurilsulfate and fluorescein sodium | Pinetarsol | 307661 | Feb 2024 to 2026 |
| PSS | Pioglitazone | Tab 15 mg | Vexazone | 2479435 | Dec 2024 to 2027 |
| PSS | Pioglitazone | Tab 30 mg | Vexazone | 2479443 | Dec 2024 to 2027 |
| PSS | Pioglitazone | Tab 45 mg | Vexazone | 2479451 | Dec 2024 to 2027 |
| PSS | Piperacillin with tazobactam | Inj 4 g with tazobactam 0.5 g vial | PipTaz-AFT | 2529866 | Dec 2025 to 2028 |
| PSS | Pneumococcal (PCV13) conjugate vaccine | Inj 30.8 mcg of pneumococcal polysaccharide serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in 0.5 ml syringe | Prevenar 13 | 2383047 | Dec 2024 to 2027 |
| PSS | Pneumococcal (PCV13) conjugate vaccine | Inj 30.8 mcg of pneumococcal polysaccharide serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in 0.5 ml syringe | Prevenar 13 | 2451085 | Dec 2024 to 2027 |
| PSS | Pneumococcal (PPV23) polysaccharide vaccine | Inj 575 mcg in 0.5 ml prefilled syringe (25 mcg of each 23 pneumococcal serotype) | Pneumovax 23 | 2478838 | Dec 2024 to 2027 |
| PSS | Poliomyelitis vaccine | Inj 80 D-antigen units in 0.5 ml syringe | IPOL | 216909 | Dec 2024 to 2027 |
| PSS | Poloxamer | Oral drops 10% | Coloxyl | 252816 | Feb 2024 to 2026 |
| PSS | Pomalidomide | Cap 1 mg | Pomolide | 2680297 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 1 mg | Pomolide | 2680300 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 2 mg | Pomolide | 2680319 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 2 mg | Pomolide | 2680327 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 3 mg | Pomolide | 2680335 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 3 mg | Pomolide | 2680343 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 4 mg | Pomolide | 2680351 | Aug 2024 to 31~Jul~2027 |
| PSS | Pomalidomide | Cap 4 mg | Pomolide | 2680378 | Aug 2024 to 31~Jul~2027 |
| PSS | Posaconazole | Oral liq 40 mg per ml | Devatis | 2645181 | Dec 2025 to 2028 |
| PSS | Posaconazole | Tab modified-release 100 mg | Posaconazole Juno | 2631008 | Dec 2025 to 2028 |
| PSS | Potassium iodate | Tab 253 mcg (150 mcg elemental iodine) | NeuroTabs | 2439964 | Feb 2024 to 2026 |
| PSS | Pramipexole hydrochloride | Tab 0.25 mg | Ramipex | 2450534 | Dec 2025 to 2028 |
| PSS | Pramipexole hydrochloride | Tab 1 mg | Ramipex | 2450542 | Dec 2025 to 2028 |
| PSS | Pravastatin | Tab 20 mg | Clinect | 2665204 | May 2024 to 2026 |
| PSS | Pravastatin | Tab 40 mg | Clinect | 2665212 | May 2024 to 2026 |
| PSS | Prednisolone | Oral liq 5 mg per ml | Redipred | 317659 | Dec 2024 to 2027 |
| PSS | Pregnancy test - hCG urine | Cassette | David One Step Cassette Pregnancy Test | 2602318 | Mar 2025 to 2027 |
| PSS | Prochlorperazine | Tab 5 mg | Nausafix | 2528886 | Mar 2024 to 2026 |
| PSS | Promethazine hydrochloride | Tab 10 mg | Allersoothe | 2238098 | Dec 2025 to 2028 |
| PSS | Promethazine hydrochloride | Tab 10 mg | Allersoothe | 2700190 | Dec 2025 to 2028 |
| PSS | Promethazine hydrochloride | Tab 25 mg | Allersoothe | 2238128 | Dec 2025 to 2028 |
| PSS | Promethazine hydrochloride | Tab 25 mg | Allersoothe | 2700204 | Dec 2025 to 2028 |
| HSS | Propranolol | Tab 10 mg | Drofate | 2611414 | Mar 2022 to 2027 |
| HSS | Propranolol | Tab 40 mg | IPCA-Propranolol | 2618664 | Mar 2022 to 2027 |
| PSS | Pyridoxine hydrochloride | Tab 25 mg | Vitamin B6 25 | 2473534 | Feb 2024 to 2026 |
| PSS | Quetiapine | Tab 100 mg | Quetapel | 2252880 | Feb 2024 to 2026 |
| PSS | Quetiapine | Tab 200 mg | Quetapel | 2252902 | Feb 2024 to 2026 |
| PSS | Quetiapine | Tab 25 mg | Quetapel | 2476266 | Feb 2024 to 2026 |
| PSS | Quetiapine | Tab 300 mg | Quetapel | 2476274 | Feb 2024 to 2026 |
| PSS | Quinapril | Tab 10 mg | Arrow-Quinapril 10 | 2427885 | Mar 2025 to 2027 |
| PSS | Quinapril | Tab 20 mg | Arrow-Quinapril 20 | 2427893 | Mar 2025 to 2027 |
| PSS | Quinapril | Tab 5 mg | Arrow-Quinapril 5 | 2427877 | Mar 2025 to 2027 |
| PSS | Ramipril | Cap 1.25 mg | Tryzan | 2635747 | Feb 2025 to 2027 |
| PSS | Ramipril | Cap 10 mg | Tryzan | 2635771 | Feb 2025 to 2027 |
| PSS | Ramipril | Cap 2.5 mg | Tryzan | 2635755 | Feb 2025 to 2027 |
| PSS | Ramipril | Cap 5 mg | Tryzan | 2635763 | Feb 2025 to 2027 |
| PSS | Remifentanil | Inj 1 mg vial | Remifentanil-AFT | 2390388 | Feb 2024 to 2026 |
| PSS | Remifentanil | Inj 2 mg vial | Remifentanil-AFT | 2390396 | Feb 2024 to 2026 |
| PSS | Rifampicin | Cap 150 mg | Rifadin | 251186 | Dec 2023 to 2026 |
| PSS | Rifampicin | Cap 300 mg | Rifadin | 251194 | Dec 2023 to 2026 |
| PSS | Rifampicin | Inj 600 mg vial | Rifadin | 698121 | Dec 2023 to 2026 |
| PSS | Rifampicin | Oral liq 100 mg per 5 ml | Rifadin | 251208 | Dec 2023 to 2026 |
| PSS | Rifaximin | Tab 550 mg | Xifaxan | 2449935 | Dec 2024 to 2027 |
| PSS | Riluzole | Tab 50 mg | Rilutek | 238732 | Feb 2025 to 2027 |
| PSS | Risperidone | Oral liq 1 mg per ml | Risperon | 2325640 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 0.5 mg | Risperidone (Teva) | 2466899 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 1 mg | Risperidone (Teva) | 2466902 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 2 mg | Risperidone (Teva) | 2466910 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 3 mg | Risperidone (Teva) | 2466929 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 4 mg | Risperidone (Teva) | 2466937 | Mar 2024 to 2026 |
| PSS | Rivaroxaban | Tab 10 mg | Xarelto | 2545152 | Dec 2023 to 2026 |
| PSS | Rivaroxaban | Tab 15 mg | Xarelto | 2425920 | Dec 2023 to 2026 |
| PSS | Rivaroxaban | Tab 20 mg | Xarelto | 2425947 | Dec 2023 to 2026 |
| PSS | Rivastigmine | Patch 4.6 mg per 24 hour | Rivastigmine Patch BNM 5 | 2611570 | Mar 2025 to 2027 |
| PSS | Rivastigmine | Patch 9.5 mg per 24 hour | Rivastigmine Patch BNM 10 | 2611589 | Mar 2025 to 2027 |
| PSS | Rizatriptan | Tab orodispersible 10 mg | Rizamelt | 2394634 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 10 mg per ml, 10 ml ampoule | Ropivacaine Kabi | 2478749 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 10 mg per ml, 20 ml ampoule | Ropivacaine Kabi | 2478765 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 2 mg per ml, 10 ml ampoule | Ropivacaine Kabi | 2478757 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 2 mg per ml, 20 ml ampoule | Ropivacaine Kabi | 2478714 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 2 mg per ml, 100 ml bag | Ropivacaine Kabi | 2479125 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 2 mg per ml, 200 ml bag | Ropivacaine Kabi | 2479117 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 7.5 mg per ml, 10 ml ampoule | Ropivacaine Kabi | 2478722 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 7.5 mg per ml, 20 ml ampoule | Ropivacaine Kabi | 2478730 | Feb 2024 to 2026 |
| PSS | Rosuvastatin | Tab 10 mg | Rosuvastatin Viatris | 2651149 | Oct 2024 to 2026 |
| PSS | Rosuvastatin | Tab 20 mg | Rosuvastatin Viatris | 2651157 | Apr 2024 to 2026 |
| PSS | Rosuvastatin | Tab 40 mg | Rosuvastatin Viatris | 2651165 | Apr 2024 to 2026 |
| PSS | Rosuvastatin | Tab 5 mg | Rosuvastatin Viatris | 2651130 | Oct 2024 to 2026 |
| PSS | Rotavirus oral vaccine | Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, prefilled oral applicator | Rotarix | 2509415 | Dec 2024 to 2027 |
| PSS | Roxithromycin | Tab 150 mg | Arrow-Roxithromycin | 2246236 | Aug 2023 to 2026 |
| PSS | Roxithromycin | Tab 300 mg | Arrow-Roxithromycin | 2246228 | Aug 2023 to 2026 |
| PSS | Salbutamol | Oral liq 400 mcg per ml | Ventolin | 2140543 | May 2025 to 2027 |
| PSS | Sildenafil | Tab 100 mg | Vedafil | 2377810 | Dec 2024 to 2027 |
| PSS | Sildenafil | Tab 25 mg | Vedafil | 2377764 | Dec 2024 to 2027 |
| PSS | Sildenafil | Tab 50 mg | Vedafil | 2377780 | Dec 2024 to 2027 |
| PSS | Simvastatin | Tab 10 mg | Simvastatin Mylan | 2520087 | Mar 2024 to 2026 |
| PSS | Simvastatin | Tab 20 mg | Simvastatin Viatris | 2643561 | Mar 2024 to 2026 |
| PSS | Simvastatin | Tab 40 mg | Simvastatin Viatris | 2643588 | Jun 2024 to 2026 |
| PSS | Simvastatin | Tab 80 mg | Simvastatin Viatris | 2643596 | Jun 2024 to 2026 |
| PSS | Sodium citro-tartrate | Grans eff 4 g sachets | Ural | 298638 | Feb 2024 to 2026 |
| PSS | Sodium fusidate [Fusidic acid] | Crm 2% | Foban | 2556170 | Feb 2025 to 2027 |
| PSS | Sodium fusidate [Fusidic acid] | Oint 2% | Foban | 2556189 | Feb 2025 to 2027 |
| PSS | Sodium hyaluronate [Hyaluronic acid] | Eye drops 1 mg per ml | Hylo-Fresh | 2608162 | Dec 2024 to 2027 |
| PSS | Solifenacin succinate | Tab 10 mg | Solifenacin succinate Max Health | 2690616 | Jun 2025 to 2027 |
| PSS | Solifenacin succinate | Tab 5 mg | Solifenacin succinate Max Health | 2690608 | Jun 2025 to 2027 |
| PSS | Somatropin | Inj 10 mg cartridge | Omnitrope | 2461528 | Feb 2025 to 2027 |
| PSS | Somatropin | Inj 15 mg cartridge | Omnitrope | 2461501 | Feb 2025 to 2027 |
| PSS | Somatropin | Inj 5 mg cartridge | Omnitrope | 2461536 | Feb 2025 to 2027 |
| PSS | Sugammadex | Inj 100 mg per ml, 2 ml vial | Sugammadex BNM | 2632314 | Dec 2024 to 2027 |
| PSS | Sugammadex | Inj 100 mg per ml, 5 ml vial | Sugammadex BNM | 2632322 | Dec 2024 to 2027 |
| PSS | Sumatriptan | Inj 12 mg per ml, 0.5 ml prefilled pen | Clustran | 2647958 | Dec 2025 to 2028 |
| HSS | Sumatriptan | Tab 100 mg | Sumagran | 2605856 | Feb 2022 to 2027 |
| HSS | Sumatriptan | Tab 50 mg | Sumagran | 2605848 | Feb 2022 to 2027 |
| PSS | Suxamethonium chloride | Inj 50 mg per ml, 2 ml ampoule | Martindale | 2442205 | Feb 2024 to 2026 |
| PSS | Tacrolimus | Oint 0.1% | Zematop | 2607646 | Dec 2023 to 2026 |
| PSS | Tamoxifen citrate | Tab 10 mg | Tamoxifen Sandoz | 2556944 | Dec 2023 to 2026 |
| PSS | Tamoxifen citrate | Tab 20 mg | Tamoxifen Sandoz | 2556952 | Dec 2023 to 2026 |
| PSS | Teicoplanin | Inj 400 mg vial | Teicoplanin Medsurge | 2664372 | Apr 2025 to 2027 |
| PSS | Temazepam | Tab 10 mg | Normison | 2184877 | Feb 2024 to 2026 |
| PSS | Tenofovir disoproxil | Tab 245 mg (300 mg as a maleate) | Tenofovir Disoproxil Viatris | 2638061 | Dec 2025 to 2028 |
| PSS | Terbinafine | Tab 250 mg | Deolate | 2597160 | Feb 2024 to 2026 |
| PSS | Teriflunomide | Tab 14 mg | Teriflunomide Sandoz | 2691426 | Apr 2025 to 2026 |
| PSS | Terlipressin | Inj 0.2 mg per ml, 5 ml vial | Terlipressin Ever Pharma | 2689359 | Feb 2025 to 2027 |
| PSS | Testosterone | Gel (transdermal) 16.2 mg per g, 88 g | Testogel | 2703092 | Apr 2025 to 2027 |
| PSS | Thiotepa | Inj 100 mg vial | Tepadina | 2487977 | Apr 2024 to 2026 |
| PSS | Thiotepa | Inj 15 mg vial | Tepadina | 2487985 | Apr 2024 to 2026 |
| PSS | Ticagrelor | Tab 90 mg | Ticagrelor Sandoz | 2638770 | Dec 2024 to 2027 |
| PSS | Timolol | Eye drops 0.25% | Arrow-Timolol | 2390663 | Mar 2024 to 2026 |
| PSS | Timolol | Eye drops 0.5% | Arrow-Timolol | 2390655 | Mar 2024 to 2026 |
| PSS | Tobramycin | Solution for inhalation 60 mg per ml, 5 ml | Tobramycin BNM | 2601648 | Dec 2023 to 2026 |
| PSS | Tobramycin | Inj 40 mg per ml, 2 ml vial | Tobramycin (Viatris) | 2635690 | Dec 2024 to 2027 |
| PSS | Tramadol hydrochloride | Cap 50 mg | Arrow-Tramadol | 2351889 | Jan 2024 to 2026 |
| PSS | Tramadol hydrochloride | Inj 50 mg per ml, 2 ml ampoule | Tramal 100 | 471216 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Inj 50 mg per ml, 2 ml ampoule | Tramal 100 | 2650932 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Inj 50 mg per ml, 1 ml ampoule | Tramal 50 | 471208 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Inj 50 mg per ml, 1 ml ampoule | Tramal 50 | 2650940 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 100 mg | Tramal SR 100 | 2149508 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 100 mg | Tramal SR 100 | 2650959 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 150 mg | Tramal SR 150 | 2149532 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 150 mg | Tramal SR 150 | 2650967 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 200 mg | Tramal SR 200 | 2149524 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 200 mg | Tramal SR 200 | 2650975 | May 2024 to 2026 |
| PSS | Tranexamic acid | Inj 100 mg per ml, 10 ml ampoule | Tranexamic-AFT | 2497174 | Mar 2025 to 2027 |
| PSS | Tranexamic acid | Inj 100 mg per ml, 5 ml ampoule | Tranexamic-AFT | 2497166 | Mar 2025 to 2027 |
| PSS | Trastuzumab (Herzuma) | Inj 150 mg vial | Herzuma | 2670127 | Jun 2024 to 31~May~2027 |
| PSS | Trastuzumab (Herzuma) | Inj 440 mg vial | Herzuma | 2670135 | Jun 2024 to 31~May~2027 |
| PSS | Travoprost | Eye drops 0.004% | Travatan | 2550091 | Dec 2024 to 2027 |
| PSS | Tretinoin | Crm 0.05% | ReTrieve | 2358751 | Feb 2025 to 2027 |
| PSS | Triamcinolone acetonide | Paste 0.1% | Kenalog in Orabase | 253790 | Feb 2024 to 2026 |
| PSS | Triamcinolone acetonide | Crm 0.02% | Aristocort | 250066 | Feb 2024 to 2026 |
| PSS | Triamcinolone acetonide | Oint 0.02% | Aristocort | 250082 | Feb 2024 to 2026 |
| PSS | Triamcinolone acetonide | Inj 10 mg per ml, 1 ml ampoule | Kenacort-A 10 | 282499 | Feb 2024 to 2026 |
| PSS | Triamcinolone acetonide | Inj 40 mg per ml, 1 ml ampoule | Kenacort-A 40 | 253766 | Feb 2024 to 2026 |
| PSS | Trimethoprim | Tab 300 mg | TMP | 648507 | Feb 2025 to 2027 |
| PSS | Trimethoprim with sulphamethoxazole [Co-trimoxazole] | Oral liq 8 mg with sulphamethoxazole 40 mg per ml | Deprim | 2309718 | Aug 2025 to 2028 |
| PSS | Trimethoprim with sulphamethoxazole [Co-trimoxazole] | Tab 80 mg with sulphamethoxazole 400 mg | Trisul | 283363 | Feb 2025 to 2027 |
| PSS | Tuberculin PPD [Mantoux] test | Inj 5 TU per 0.1 ml, 1 ml vial | Tubersol | 703338 | Dec 2024 to 2027 |
| PSS | Ursodeoxycholic acid | Cap 250 mg | Ursosan | 2397528 | Feb 2024 to 2026 |
| PSS | Valaciclovir | Tab 1,000 mg | Vaclovir | 2483912 | Feb 2025 to 2027 |
| PSS | Valaciclovir | Tab 500 mg | Vaclovir | 2483904 | Feb 2025 to 2027 |
| PSS | Valganciclovir | Tab 450 mg | Valganciclovir Viatris | 2635682 | Feb 2025 to 2027 |
| PSS | Vancomycin | Inj 500 mg vial | Mylan | 2195267 | Feb 2024 to 2026 |
| PSS | Varicella vaccine [Chickenpox vaccine] | Inj 2000 PFU prefilled syringe plus vial | Varilrix | 2678950 | Dec 2024 to 2027 |
| PSS | Vecuronium bromide | Inj 10 mg vial | Vecure | 2503379 | Apr 2025 to 2027 |
| PSS | Voriconazole | Inj 200 mg vial | AFT | 2645122 | Dec 2025 to 2028 |
| PSS | Voriconazole | Tab 200 mg | Vttack | 2474875 | Aug 2025 to 2028 |
| PSS | Voriconazole | Tab 50 mg | Vttack | 2474867 | Aug 2025 to 2028 |
| PSS | Zoledronic acid | Inj 4 mg per 5 ml, vial | Zoledronic acid Viatris | 2631830 | Dec 2024 to 2027 |
| PSS | Zopiclone | Tab 7.5 mg | Zopiclone Actavis | 2480662 | Feb 2025 to 2027 |